Explore every aspect of life with kidney disease
A systematic review and meta-analysis compared multiple drug classes in type 1 diabetes (T1DM) patients for kidney markers and safety; results showed an overall reduction in urine…
A systematic review found limited and inconsistent evidence on the effects of SGLT2 inhibitors on bone health in CKD patients, with particularly scarce data in advanced CKD populations [1].
A single-arm meta-analysis of diabetic patients with biopsy-proven MASH found SGLT2 inhibitors were associated with improvements in multiple liver, metabolic, and histologic markers versus…
About 590 million adults have diabetes, and roughly 40% will develop diabetic kidney disease — the leading cause of dialysis worldwide.
Heart failure doesn't mean the heart has stopped — it means it can't pump enough for the body's needs.
Add Beyond CKD to your home screen
Open it like an app, and read articles and tools you have visited even when offline.